Mokrani, David
Chommeloux, Juliette
Pineton de Chambrun, Marc
Hékimian, Guillaume
Luyt, Charles-Edouard http://orcid.org/0000-0001-7424-2705
Article History
Received: 5 January 2023
Accepted: 20 April 2023
First Online: 6 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: C.<b>-</b>E. L. received lecture fees from Merck, Aerogen and Advanz Pharma, outside the submitted work. The other authors have no conflicts of interest to declare in relationship to this manuscript.